RESEARCH & PROJECTS
SCIENCE & PROJECTS
2021 to approx. 2026
MAESTRIA – AFNET 10
Machine learning, artificial intelligence, early detection, stroke, atrial fibrillation.
2017 – 2023
AXADIA – AFNET 8
Safety Study Assessing Oral Anticoagulation with Apixaban versus Vitamin-K Antagonists in Patients with Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment
Machine learning
2021 – 2022
Smart in OAC-AFNET 9
Remote, investigator-initiated Smartphone and wearable detected atrial arrhythmia in Older Adults Case finding study
2016 – 2023
NOAH- AFNET 6
Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High-rate episodes
2011 – 2021
EAST – AFNET 4
Early treatment of atrial fibrillation for stroke prevention trial (EAST)
2015 – 2018
AXAFA – AFNET 5
Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy (AXAFA)
2024 to approx. 2030
EASThigh – AFNET 11
Early atrial fibrillation ablation for stroke prevention in patients with a high comorbidity burden
2006 – 2011
Gap-AF – AFNET 1 study
Catheter ablation of arial fibrillation by linear pulmonary vein isolation
2005 – 2012
Flec-SL – AFNET 3 Study
Targeted Pharmacological Reversal of Electrical Remodeling After Cardioversion.
2005 – 2009
ANTIPAF – AFNET 2 study
Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation Trial (ANTIPAF Trial)
You can help!
Doctors with expertise
Contact us directly to actively participate in our ongoing studies, be it through patient recruitment, as investigator or consultant
2004 – 2010
Studie AFNET 99 Studie
Frühe Behandlung von Vorhofflimmern zur Verhinderung von Schlaganfällen
2030
2029
2028
2027
2026
2004 – 2010
Studie AFNET 99 Studie
Frühe Behandlung von Vorhofflimmern zur Verhinderung von Schlaganfällen